| Primary |
| Depression |
33.1% |
| Product Used For Unknown Indication |
21.0% |
| Drug Use For Unknown Indication |
5.7% |
| Anxiety |
5.1% |
| Nosocomial Infection |
3.8% |
| Overdose Intentional |
3.8% |
| Post-traumatic Stress Disorder |
3.2% |
| Schizophrenia, Paranoid Type |
3.2% |
| Obsessive-compulsive Disorder |
2.5% |
| Drug Use For Unknown Indication |
1.9% |
| Adjustment Disorder |
1.9% |
| Bipolar Disorder |
1.9% |
| Hypertension |
1.9% |
| Insomnia |
1.9% |
| Major Depression |
1.9% |
| Panic Attack |
1.9% |
| Parkinson's Disease |
1.9% |
| Pain |
1.3% |
| Seizures |
1.3% |
| Cutaneous T-cell Lymphoma |
0.6% |
|
| Tremor |
15.1% |
| Weight Decreased |
7.5% |
| Breast Cancer |
5.7% |
| Maternal Drugs Affecting Foetus |
5.7% |
| Skin Exfoliation |
5.7% |
| Suicide Attempt |
5.7% |
| Visual Impairment |
5.7% |
| Completed Suicide |
3.8% |
| Increased Tendency To Bruise |
3.8% |
| Miosis |
3.8% |
| Pain In Jaw |
3.8% |
| Paraesthesia |
3.8% |
| Sepsis |
3.8% |
| Suicidal Ideation |
3.8% |
| Syncope |
3.8% |
| Tachycardia |
3.8% |
| Thinking Abnormal |
3.8% |
| Tic |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Umbilical Artery Hypoplasia |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
54.3% |
| Depression |
11.0% |
| Intentional Overdose |
4.7% |
| Attempted Suicide |
3.9% |
| Nosocomial Infection |
3.9% |
| Drug Use For Unknown Indication |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Prophylaxis |
3.1% |
| Generalised Anxiety Disorder |
1.6% |
| Major Depression |
1.6% |
| Psychotic Disorder |
1.6% |
| Suicide Attempt |
1.6% |
| Compulsions |
0.8% |
| Obsessive-compulsive Disorder |
0.8% |
| Gait Disturbance |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Headache |
0.8% |
| Personality Disorder |
0.8% |
| Procedural Pain |
0.8% |
| Type 1 Diabetes Mellitus |
0.8% |
|
| Toxicity To Various Agents |
14.8% |
| Tremor |
11.1% |
| Renal Failure Acute |
7.4% |
| Suicide Attempt |
7.4% |
| Atrioventricular Block Complete |
3.7% |
| Completed Suicide |
3.7% |
| Disease Progression |
3.7% |
| Drug Abuse |
3.7% |
| Fall |
3.7% |
| Female Sexual Arousal Disorder |
3.7% |
| Hepatitis |
3.7% |
| Hypoglycaemia Neonatal |
3.7% |
| Hypogonadism |
3.7% |
| Liver Disorder |
3.7% |
| Maternal Drugs Affecting Foetus |
3.7% |
| Pain |
3.7% |
| Renal Failure Chronic |
3.7% |
| Respiratory Disorder |
3.7% |
| Serotonin Syndrome |
3.7% |
| Somnolence |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.0% |
| Depression |
11.1% |
| Anxiety |
5.6% |
| Colon Cancer |
5.6% |
| Colon Cancer Stage Ii |
5.6% |
| Gait Disturbance |
5.6% |
| Hypertension |
5.6% |
| Nephrogenic Anaemia |
5.6% |
| Asthma |
3.7% |
| Bipolar Disorder |
3.7% |
| Constipation |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Irritable Bowel Syndrome |
3.7% |
| Major Depression |
3.7% |
| Multiple Sclerosis |
3.7% |
| Psoriasis |
3.7% |
| Psychosis |
3.7% |
| Stem Cell Transplant |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Abdominal Pain |
1.9% |
|
| Vomiting |
11.1% |
| Drug Ineffective |
7.4% |
| Irritability |
7.4% |
| Urinary Tract Infection |
7.4% |
| Vascular Graft Thrombosis |
7.4% |
| Wheezing |
7.4% |
| Biliary Cirrhosis Primary |
3.7% |
| Blood Cholesterol Increased |
3.7% |
| Diarrhoea |
3.7% |
| Dyspepsia |
3.7% |
| Fatigue |
3.7% |
| Feeling Abnormal |
3.7% |
| Hallucination, Visual |
3.7% |
| Headache |
3.7% |
| Hepatic Enzyme Increased |
3.7% |
| Insomnia |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Loss Of Consciousness |
3.7% |
| Myalgia |
3.7% |
| Off Label Use |
3.7% |
|
